Novocure Reports First Quarter 2024 Financial Results
Quarterly net revenues of $139 million, up 13% year-over-year, with 3,845 active patients on therapy as of March 31, 2024 Phase 3 METIS trial in brain metastases from non-small cell lung cancer met...
Source: marketscreener.com